Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine efficacy for uncomplicated falciparum malaria in Botswana
ACTRN12609000276257Phase 4Terminated
- Sponsor
- Ministry of Health
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in Malaria, sponsored by Ministry of Health. Primary endpoint: Clinical and parasitological efficacy. Started Apr 2009; status: terminated.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12609000276257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000276257.